Search

Background: Hypercholesterolemia is a major risk factor for cardiovascular events in patients with established atherosclerotic disease (EAD) and in those with multiple risk factors (MRFs). This study aimed to investigate the rate of optimal low-density lipoprotein (LDL) cholesterol level in a multicenter registry of patients at high risk for cardiovascular events., Methods: A multicenter registry of EAD and MRF patients was conducted. Demographic data, medical history, cardiovascular risk factors, anthropometric data, laboratory data, and medications were recorded and analyzed. We classified patients according to target LDL levels based on recommendation by the European Society of Cardiology (ESC) 2011 into Group 1 which is EAD and diabetes or chronic kidney disease (CKD)-target LDL below 70 mg/dL, and Group 2 which is MRF without diabetes or CKD-target LDL below 100 mg/dL. The rate of optimal LDL level in patients with Group 1 and Group 2 was analyzed and stratified according to the treatment pattern of lipid-lowering medications., Results: A total of 3100 patients were included. Of those, 51.7% were male. Average age was 65.8 ± 9.7 years. Average LDL level was 96.3 ± 32.6 mg/dL. A vast majority (92.7%) received statin and 9.3% received ezetimibe. Optimal LDL level was achieved in 20.3% of patients in Group 1 (LDL < 70 mg/dL), and in 46.6% in Group 2 (LDL < 100 mg/dL). The overall rate of optimal LDL control was 23% since 89.6% of study population belongs to Group 1. The rate of optimal LDL was not different between high and low potency statin. Factors that were associated with optimal LDL control were older age, the presence of coronary artery disease or peripheral artery disease., Conclusions: The rates of optimal LDL level were unacceptably low in this study population. As such, a strategy to improve LDL control in high-risk population should be implemented.

Objective: To review the changing clinical profile of isolated coronary artery bypass graft (CABG) surgery patients at the University of Alberta Hospitals during the past two decades., Design: Data were obtained retrospectively by review of patients' hospital charts and cardiologists' charts. The three patient cohorts consisted of the first 411 consecutive patients who underwent isolated CABG surgery between 1970 and 1974, 302 consecutive patients who had CABG surgery in 1984 and 346 consecutive patients who had the operation in 1989., Results: Patients who underwent CABG surgery in 1984 and 1989 were older than patients undergoing the same operation in the 1970s. Emergency and/or urgent operations and the number of patients with prior myocardial infarct were increased significantly in 1984 and 1989. The incidence of patients with multiple vessel disease and left main stem stenosis increased significantly over the two decades. The number of bypass grafts per patient and the use of internal mammary grafts have increased since 1970. The endarterectomy procedure was performed less frequently in 1984 and 1989. The use of radial artery grafts has been discontinued. Perioperative mortality remained stable throughout the study period despite an increasing incidence of high risk patients. The major cause of death was pump failure. The incidence of peripostoperative myocardial infarct was higher in the 1970s. A multivariate analysis of the 1984 and 1989 cohorts was performed to identify temporal trends in risk factors. Emergency surgery, preoperative heart failure, age (older than 65 years), prior CABG surgery and preoperative renal failure are significant predictors of operative motility., Conclusions: The clinical profile of patients for isolated CABG surgery has changed over the years. The mortality rate has been stable over two decades despite the advancement of medical and surgical practices, representing a balance of increasingly high risk patients presenting for CABG surgery.

Objective: This study reviews the short and long term outcomes of patients who underwent isolated mitral valve replacement at the University of Alberta Hospitals during the past decade., Design: Data were obtained retrospectively by review of patients' hospital charts, cardiologists' follow-up charts, contact with patients' physicians, and direct telephone or mail contact with patients and/or their surviving relatives., Results: The clinical outcomes of 198 consecutive patients (124 women and 74 men) who underwent isolated mitral valve replacement from January 1981 to December 1990 at the University of Alberta Hospital were reviewed. Overall early operative mortality was 11%. Deaths were mainly related to pump failure and previous mitral valve replacement. Late mortality was 17%. Follow-up data were available except in five patients. Average follow-up was 6.3 years. Overall cumulative survival was 72.9 +/- 3.4% at five years and 63.1 +/- 4.8% at 10 years. The cumulative freedom from complications was 64.3 +/- 3.9% and 36.4 +/- 4.9% at five and 10 years, respectively. Long term survival rates obtained after isolated mitral valve replacement are higher than those reported in series of medically treated patients with mitral valve disease., Conclusions: Mitral valve replacement can prolong survival as well as improve symptoms in patients with symptomatic mitral valve disease.

Between January 1982 and June 1989, 102 consecutive patients (25 women and 77 men) who had isolated aortic valve replacements were reviewed. The overall early operative mortality was 5%. The deaths were related mainly to pump failure and endocarditis. The early operative mortality in younger patients (less than 70 years old) was 3.5% and in the elderly (70 or older) 11%. The overall late mortality was 4%. All of the survivors except three (follow-up by telephone) were seen in follow-up by cardiologists. The mean follow-up was 40 +/- 26 months (range four to 89). Eighty-seven per cent of all patients or 92% of the survivors in the younger population did well following the operation. In the elderly patients, the results were less favorable (P less than 0.025). The overall cumulative survival was 92% at one year and 89% at five years. The actuarial event-free percentage of survivors was 86% at one year and 74% at five years. Aortic valve replacement can be accomplished in symptomatic patients with an acceptable operative mortality. Long term follow-up of these patients showed functional improvement and low mortality.

The clinical and angiographic variables of 26 coronary artery disease patients at the University of Alberta Hospitals requiring emergency coronary artery bypass grafting (CABG) for failed percutaneous transluminal coronary angioplasty (PTCA) were reviewed. Emergency CABG was judged necessary in 2% of 1300 consecutive patients undergoing PTCA. The most frequent indication for an emergency operation was dissection and acute closure of eccentric bend point target lesions associated with clinically severe, unremitting chest pain and ST-T abnormalities suggestive of impending myocardial infarction. The mortality rate for the combined procedures of failed PTCA and CABG was low (3.8%). The incidence of periprocedural infarction was high (61%); it was, however, associated with a benign clinical course and electrocardiographic evidence of significant reversibility of acute phase damage. Thus, overall, emergency CABG appears to be a clinically efficacious treatment for patients with threatened or impending infarction as a consequence of failed PTCA.